| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/03/2015 | US8945589 Immunogenic compositions for Streptococcus agalactiae |
| 02/03/2015 | US8945588 Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| 02/03/2015 | US8945587 Synthetic lipid biology for combinatorial engineering of endotoxin |
| 02/03/2015 | US8945586 Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin |
| 02/03/2015 | US8945585 Multi-Target recombination gene and the application of its protein to prevent and cure Helicobacter pylori |
| 02/03/2015 | US8945584 Cell culture system of a hepatitis C genotype 3a and 2a chimera |
| 02/03/2015 | US8945582 Vaccine |
| 02/03/2015 | US8945581 Process for producing poxviruses and poxvirus compositions |
| 02/03/2015 | US8945580 Yersinia pestis antigens, vaccine compositions, and related methods |
| 02/03/2015 | US8945579 Methods of treatment with compositions that include hemagglutinin |
| 02/03/2015 | US8945578 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 02/03/2015 | US8945577 Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A |
| 02/03/2015 | US8945576 Vaccine for treatment of tautopathy |
| 02/03/2015 | US8945575 Treatment of IgE-mediated disease |
| 02/03/2015 | US8945574 Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
| 02/03/2015 | US8945573 Targeted identification of immunogenic peptides |
| 02/03/2015 | US8945572 Methods and compositions for the diagnosis and treatment of cancer |
| 02/03/2015 | US8945571 Targeted immunoconjugates |
| 02/03/2015 | US8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/03/2015 | US8945569 Jagged-binding agents and uses thereof |
| 02/03/2015 | US8945568 Pneumococcal Serotype 6D |
| 02/03/2015 | US8945567 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 02/03/2015 | US8945566 Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease |
| 02/03/2015 | US8945565 Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies |
| 02/03/2015 | US8945564 Antagonist anti-CD40 antibody pharmaceutical compositions |
| 02/03/2015 | US8945563 Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 02/03/2015 | US8945562 Anti-complement C1s antibodies |
| 02/03/2015 | US8945561 Receptor modulators |
| 02/03/2015 | US8945560 Method of treating rheumatoid arthritis using antibody to IL6R |
| 02/03/2015 | US8945559 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies |
| 02/03/2015 | US8945558 Methods for treating myocardial infarction comprising administering an IL-6 inhibitor |
| 02/03/2015 | US8945557 Use of immunesuppressant receptor |
| 02/03/2015 | US8945556 RAF gene fusions |
| 02/03/2015 | US8945555 Inotropic antibodies and therapeutic uses thereof |
| 02/03/2015 | US8945554 Class I anti-CEA antibodies and uses thereof |
| 02/03/2015 | US8945553 Bispecific antibodies to IL-23 and IL-17A/F |
| 02/03/2015 | US8945552 Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies |
| 02/03/2015 | US8945551 Biopolymer hybrid gel-depot delivery system |
| 02/03/2015 | US8945550 Antibodies and methods for making and using them |
| 02/03/2015 | US8945549 Methods of treating antinociceptive tolerance |
| 02/03/2015 | US8945548 Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders |
| 02/03/2015 | US8945547 Notch1 receptor antibodies and methods of treatment |
| 02/03/2015 | US8945546 IP-10 antibodies and their uses |
| 02/03/2015 | US8945545 Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23 |
| 02/03/2015 | US8945544 Immunogenic compositions comprising progastrin and uses thereof |
| 02/03/2015 | US8945543 Stabilizer for protein preparation comprising meglumine and use thereof |
| 02/03/2015 | US8945531 Recombinant herpes virus and pharmaceutical composition containing the same |
| 02/03/2015 | US8945530 DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4 |
| 02/03/2015 | CA2800113C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 02/03/2015 | CA2790018C Formulations |
| 02/03/2015 | CA2775793C Siglec 15 antibodies in treating bone loss-related disease |
| 02/03/2015 | CA2747180C Use of flt3 ligand for enhancing immune responses in rna immunization |
| 02/03/2015 | CA2660375C Attenuated polioviruses |
| 02/03/2015 | CA2643496C The therapeutic use of igg as a neuroprotective agent |
| 02/03/2015 | CA2633486C Multivalent immunoglobulin-based bioactive assemblies |
| 02/03/2015 | CA2617506C Immunogenic constructs useful for treating mycobacterium avium subspecies paratuberculosis (map) infection |
| 02/03/2015 | CA2583417C Antagonists and methods of use therefor |
| 02/03/2015 | CA2563024C Method for treating autoimmune diseases with antibodies |
| 02/03/2015 | CA2519620C Humanized anti-cd4 antibody with immunosuppressive properties |
| 02/03/2015 | CA2492377C Recombinant production of mixtures of antibodies |
| 02/03/2015 | CA2465009C Cytotoxin with a subtilase domain |
| 02/03/2015 | CA2452593C Triple polypeptide complexes |
| 02/03/2015 | CA2436671C Rationally designed antibodies |
| 02/03/2015 | CA2222283C Improved virus vaccines |
| 01/29/2015 | WO2015013669A1 Mps peptides and use thereof |
| 01/29/2015 | WO2015013668A1 Anti-immunoglobulin e antibodies and methods of use thereof |
| 01/29/2015 | WO2015013551A1 Conformationally stabilized rsv pre-fusion f proteins |
| 01/29/2015 | WO2015013508A2 Methods for diagnosing and treating immune disease |
| 01/29/2015 | WO2015013461A2 Cancer vaccination with antigen evolution |
| 01/29/2015 | WO2015013429A1 Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (tag-72) |
| 01/29/2015 | WO2015013390A1 Anti-hiv dual specificity antibodies and methods of hiv treatment |
| 01/29/2015 | WO2015013389A2 Anti-galectin-1 (gal1) monoclonal antibodies and fragments thereof for neutralizing gal1 |
| 01/29/2015 | WO2015013178A1 Infectious laryngotracheitis virus (iltv) vaccine using recombinant newcastle disease virus vector |
| 01/29/2015 | WO2015012904A2 Antibody-sn-38 immunoconjugates with a cl2a linker |
| 01/29/2015 | WO2015012175A1 Diagnostic drug and therapeutic drug for small cell lung cancer |
| 01/29/2015 | WO2015011658A1 Use of a cd6 binding partner and method based thereon |
| 01/29/2015 | WO2015011450A1 T cell receptors |
| 01/29/2015 | WO2015011334A1 Immunological adjuvant for the formulation of vaccines and leishmaniasis vaccine comprising same |
| 01/29/2015 | WO2015011261A1 Acceleration of vector virus induced immune response in avians |
| 01/29/2015 | WO2015011199A1 Stabilized antibody compositions |
| 01/29/2015 | WO2015010659A1 Use of rapamycin as vaccine adjuvant and preparation method therefor |
| 01/29/2015 | WO2015010599A1 Fabrication process of phase-transition microneedle patch |
| 01/29/2015 | WO2015010450A1 Viral immunotherapy drug complex and uses thereof |
| 01/29/2015 | WO2015010185A1 Methods for producing salmonella o- antigen capsules, compositions and uses thereof |
| 01/29/2015 | WO2014201378A9 Synergistic tumor treatment with extended-pk il -2 and adoptive cell therapy |
| 01/29/2015 | US20150033410 Methods and compositions for emergency post-infection treatment of anthrax |
| 01/29/2015 | US20150031863 Conjugating amines |
| 01/29/2015 | US20150031858 Methods of Stimulating Protective Immunity Employing Dengue Viral Antigens |
| 01/29/2015 | US20150031857 Dengue serotype 2 attenuated strain |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030682 Antigenic compositions and methods |
| 01/29/2015 | US20150030642 Polymer micro-needle array chip, preparation process and use thereof |
| 01/29/2015 | US20150030638 Ingenol Derivatives in the Reactivation of Latent HIV |
| 01/29/2015 | US20150030636 Identification and enrichment of cell subpopulations |
| 01/29/2015 | US20150030635 Activated Immunostimulatory Cell Composition and Uses Thereof |
| 01/29/2015 | US20150030634 Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine |
| 01/29/2015 | US20150030633 Application of mrna for use as a therapeutic against tumour diseases |
| 01/29/2015 | US20150030632 Fusion protein for enhancing immunogenicity of bacterial antigen/immunogen |
| 01/29/2015 | US20150030631 Compositions and methods for vaccinating against hsv-2 |
| 01/29/2015 | US20150030630 Adjuvanted formulations of rabies virus immunogens |